Research interests
Research on endogenous and exogenous ketogenic therapies among patients with heart failure[8]
As of 2024 · Last known relationship
North Carolina Medical Board license (#311914)
Senthil Selvaraj is a Duke heart failure physician-scientist whose translational research examines how cardiovascular metabolism may improve care for patients with heart failure. He is an Assistant Professor of Medicine in Duke’s Division of Cardiology and Duke Molecular Physiology Institute, using deep phenotyping, multi-omic biomarkers, exercise physiology, echocardiography, arterial stiffness, and metabolic imaging. His recent work explores endogenous and exogenous ketogenic therapies, including the KETO-HFpEF clinical trial. Selvaraj trained in internal medicine at Brigham and Women’s Hospital, where he was Chief Resident and a Preventive Cardiology Fellow in 2016 to 2017, then completed cardiovascular medicine and advanced heart failure/transplant fellowships at the University of Pennsylvania from 2017 to 2022. He earned degrees from Northwestern and the University of Pennsylvania.
Each topic is linked to its supporting source in Sources.
Training includes Fellowship in Advanced Heart Failure / Transplant at University of Pennsylvania, Fellowship in Cardiovascular Medicine at University of Pennsylvania, M.S at University of Pennsylvania, School of Medicine, and Preventive Cardiology Fellow at Brigham and Women's Hospital, plus 11 more records.
Explore education and trainingAs of 2025
As of 2022
As of 2021
As of 2021
As of 2017
As of 2017
As of 2016
As of 2012
As of 2008
As of 2024
As of 2024
Completed 2013
Research on endogenous and exogenous ketogenic therapies among patients with heart failure[8]
Translational research on the therapeutic relevance of cardiovascular metabolism to patients with heart failure[8]
Uses deep phenotyping, including exercise physiology, multi-omic biomarkers, echocardiography, arterial stiffness, and metabolic molecular imaging, to study metabolic mechanisms in heart failure[8]